Montrouge, France

Claudine Finidori

This inventor holds 1 USPTO granted patent. Top assignee: Synthelabo. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claudine Finidori. Retrieved from https://idiyas.com/inventor/claudine-finidori-egtool8m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Claudine Finidori

Introduction

Claudine Finidori is a notable inventor based in Montrouge, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance oral medication efficacy. Her work exemplifies the intersection of innovation and healthcare.

Latest Patents

Claudine holds a patent for "Pharmaceutical compositions for oral use including an NSAID and ceramides." This invention aims to improve the delivery and effectiveness of non-steroidal anti-inflammatory drugs (NSAIDs) by incorporating ceramides, which are known to enhance the absorption of active ingredients in the body. She has 1 patent to her name, showcasing her commitment to advancing pharmaceutical science.

Career Highlights

Claudine Finidori is associated with Synthelabo, a prominent company in the pharmaceutical industry. Her role at Synthelabo has allowed her to contribute to innovative research and development projects that aim to improve patient outcomes through better medication formulations. Her expertise in the field has positioned her as a valuable asset to her team.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Claudine Finidori's work in pharmaceutical innovation highlights her dedication to improving healthcare through scientific advancements. Her patent and contributions to Synthelabo reflect her significant role in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…